Eureka Therapeutics Sales Trigger Battle Card
Board hires at Eureka Therapeutics signal CAR-T scale-up. Pitch supply chain planning & FP&A solutions. Use our do-now checklist to connect, close, and drive commission.
Published on
Do not index
Do not index
🚀 Battle Card: Eureka Therapeutics, Inc.
Quick trigger: Appointment of Dr. Reginald Seeto & William S. Solari III to Board of Directors (Aug 12, 2025)
👤 Decision Maker in the News
- Dr. Reginald Seeto, Board of Directors · 🔗 LinkedIn
💡 Why It Matters
- Board additions with ops and finance heavyweights show they’re gearing up for clinical scale-up investments → Source. This Eureka Therapeutics, Inc. sales trigger is your green light to push scalable Ops & Supply Chain and FP&A solutions.
🎯 Core Pain Point
- Scaling CAR-T manufacturing & supply chain under tighter timelines
- Strengthening financial planning & governance ahead of late-stage clinical spend
💰 What to Pitch
- Primary: Supply Chain Planning Software → Accelerate ARTEMIS® production scale-up
- Expansion: FP&A & Compliance Suite → Improve budgeting accuracy and audit readiness
🗺️ Quick Context
- HQ: Emeryville, CA
- Employees: ≈ 75
- Rev: ≈ $0 M (pre-revenue)
- Website: eurekatherapeutics.com
🤼 Competitive Intel
Which other vendors you’ll probably face to win Eureka Therapeutics, Inc.’s business.
Ops & Supply Chain:
- SAP — ERP / Supply Chain Planning
- Unique edge: End-to-end visibility across production and distribution
- Evaluated by SVP Ops for global scale-up roadmap
- Kinaxis — S&OP / Demand Planning
- Unique edge: Real-time scenario modeling for volatile biosupply
- Evaluated by Dir. Supply Chain for agility gains
- Blue Yonder — Demand & Replenishment
- Unique edge: AI-driven forecasting tailored to clinical batches
- Evaluated by Head of Logistics for forecast accuracy
Finance & Governance:
- Workday — FP&A / HCM
- Unique edge: Unified financial and workforce planning
- Evaluated by CFO for cross-functional budget control
- Anaplan — Connected Planning
- Unique edge: Driver-based modeling at enterprise scale
- Evaluated by VP Finance for dynamic scenario planning
- Adaptive Insights — Business Planning Cloud
- Unique edge: Intuitive dashboards for non-finance users
- Evaluated by Controller for fast user adoption
✅ Do-Now Checklist
Connect with all decision makers on LinkedIn (links above)
Generate email + DM referencing this Eureka Therapeutics, Inc. sales trigger with the Copy-My-Prompt block (Step 7) and send first touch
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
Get more Eureka Therapeutics, Inc. sales trigger insights daily—no fluff, all pipeline.
Subscribe to NewsletterForLeads
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑<your company>❑
OFFER_BRIEF = ❑<1-line value>❑
PROOF_METRIC = ❑<metric>❑
CTA_STYLE = ❑quick_call | case_study❑
TONE = ❑friendly | punchy❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Reginald
COMPANY = Eureka Therapeutics, Inc.
DEPT = Board of Directors
SIZE = ≈ TBD
BOTTLENECK = ≈ TBD
EVENT = Appointment of Dr. Reginald Seeto to Board of Directors
DETAIL = Appointment of Dr. Reginald Seeto and William S. Solari III to Board
PAIN = ≈ TBD
SRC = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250812687577&div=41152219
SIM_CO = ≈ TBD
WIN_METRIC = ≈ TBD
NEXT_SIZE = ≈ TBD
EMP_EST = ≈ 75
REV_EST = ≈ $0 M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: ≈ TBD-person Board of Directors
Reginald—noticed your Board of Directors team is ≈ TBD.
That’s when ≈ TBD slows growth.
We helped ≈ TBD fix this with ≈ TBD.
Result: ≈ TBD.
<<CTA_STYLE=="quick_call" ? "Quick call?" : "Want the 2-min recap?">>
PS—next bottleneck hits ≈ TBD.
DM ≤45 words, TONE:
Saw your post about Appointment of Dr. Reginald Seeto and William S. Solari III to Board — ≈ TBD.
≈ TBD. ≈ TBD.
<<CTA_STYLE=="quick_call" ? "Quick chat?" : "Send case study?" >>